
Loading, please wait...

Loading, please wait...

Q1: What is the primary benefit of TAVI over traditional surgery?
TAVI is minimally invasive and does not require opening the chest bone. Therefore, patients usually recover much faster and face fewer surgical complications.
Q2: Who is an ideal candidate for a TAVI procedure?
TAVI is often recommended for patients with severe aortic stenosis who are considered high-risk for open-heart surgery due to age or other health conditions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Medanta Noida launched its Structural Heart Programme with three successful TAVI procedures, enhancing access to minimally invasive cardiac care in Delhi-NC...
5 months ago

Cutaneous leishmaniasis in HIV-coinfected patients presents unique diagnostic and therapeutic challenges, often manifesting as disseminated disease. Effective care requires systemic antileishmanial regimens and immune recovery.
Today

A comprehensive data mining study reveals how online communities discuss cannabis use during pregnancy. Learn why nonexpert advice dominates digital platforms, the maternal-fetal risks of cannabinoids, and how clinicians can proactively address patient queries with evidence-based counseling.
Today

A new temporal validation study demonstrates that machine learning models analyzing free-text EMS dispatch narratives significantly improve prehospital risk stratification for suspected cardiopulmonary emergencies, boosting predictive accuracy over traditional structured triage data alone.
Today

A comprehensive analysis of 2,764 trauma registry patients reveals that occupant ejection during rollover crashes increases mortality fourfold. Nonuse of seatbelts escalates ejection risk tenfold, highlighting the urgent need for strict restraint compliance and targeted road-safety interventions.
Today

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today